We are live on ! Find out more
ALTU

Altus Pharmaceuticals
ALTU

Delisted

ALTU was delisted on the 20th of November, 2009.

Back to rankings

1 hedge funds and large institutions have $1K invested in Altus Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCP
Syntal Capital Partners
Texas
+$1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCP
1
Syntal Capital Partners
Texas
$1K +$1K +66,000 New

ALTU Hedge Fund Activity: Q2 2019 in Review

1 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Altus Pharmaceuticals (ALTU) for Q2 2019, worth a combined $1K.

Buyers outnumbered sellers: 1 fund opened new ALTU positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Syntal Capital Partners, opening a new position worth an estimated $1K.

  • 1 institutional investor held Altus Pharmaceuticals (ALTU) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $1K of Altus Pharmaceuticals stock for Q2 2019.
  • 1 fund opened new Altus Pharmaceuticals positions in Q2 2019 and 0 closed out, a net change of +1 holder.
  • The largest Altus Pharmaceuticals buyer in Q2 2019 was Syntal Capital Partners, an estimated $1K added.

Based on aggregated 13F filings for Q2 2019.